Not available in the USA
With immunoassay testing at the point of care (POC), you no longer have to wait for critical test results from the lab. The Radiometer AQT90 FLEX analyzer delivers results in 11-21 minutes.
You can run immunoassay tests such as cardiac, coagulation and infection biomarkers at POC. This not only allows you to stay close to your critically ill patient, but it also helps you:
- Diagnose or rule out critical conditions
- Initiate treatment faster, improving the odds for the patient’s recovery
The AQT90 FLEX covers an extensive range of critical biomarkers at point-of-care; TnI, TnT, CKMB, Myo, NT-proBNP, PCT, CRP, D-Dimer and βhCG.
Accelerate patient flow with point-of-care testing
Point-of-care (POC) testing has many advantages, such as:
- A significant reduction in turnaround times [1]
- The ability to improve the patient pathway and help increase clinical efficiency [2]
- The potential to mitigate overcrowding [3]
The AQT90 FLEX analyzer’s closed tube system brings ease of use of POC testing to a new level.
Take the collection tube and insert it into the AQT90 FLEX immunoassay analyzer. Then get the results delivered directly through the HIS/LIS system to the medical records.
Simply Drop'n'Go.
Read more about the extensive range of biomarkers
Heart failure: NT-proBNP
Myocardial infarction: TnI, TnT, CKMB, Myo
Venous thromboembolism: D-dimer
Infection: PCT, CRP
Pregnancy: ßhCG
The immunoassay analyzer can be your Simple Zone
Welcome to The Simple Zone, where point-of-care (POC) testing is as simple as Drop'n'Go.
The AQT90 FLEX immunoassay analyzer is a POC device where no manual pipetting, sample or test kit preparation are needed. You test using whole blood or plasma samples* — simply Drop'n'Go.
*For the D-dimer assay, only whole blood samples can be used.
Image Credit: Radiometer
Make critical decisions fast
Fast turnaround time at the point of care has the potential to improve the quality of care [3].
The AQT90 FLEX immunoassay analyzer delivers reliable results with a fast turnaround time. It has the capability to run up to 5 different tests per blood sample. The AQT90 FLEX covers an extensive range of critical biomarkers at POC.
You get results in 11-21 minutes based on the biomarker you’re testing. The immunoassay analyzer allows you to initiate up to 30 tests per hour – you can manage more patients at the same time.
Image Credit: Radiometer
Meet your regulatory needs
Meet compliance and regulatory demands with the AQT90 FLEX immunoassay analyzer. The analyzer includes:
- 24/7 connectivity to HIS/LIS directly
- Reliable results with built-in QC
You can also manage multiple AQT90 FLEX analyzers with the AQURE POC IT solution. Stay ahead of compliance and accreditation needs with AQURE. It allows you to monitor analyzers and manage operators and quality controls across multiple sites. And this can all be done without leaving your desk.
Image Credit: Radiometer
Optimize your resources with POCT
Overcrowding in the ED is a widely acknowledged problem and can have an impact on the rest of the hospital.
However fast turnaround times with POC technologies can help speed up diagnosis and treatment processes. It can also reduce contingencies and process costs [4].
The AQT90 FLEX immunoassay analyzer is a reliable solution. It supports healthcare institutions that need to accelerate patient flow.
Image Credit: Radiometer
Make timely treatment decisions based on immunoassay tests without the worry of biotin interference.
The AQT90 FLEX immunoassay analyzer and assasys have been tested for biotin interference. The results show no notable biotin interference in concentrations up to 2,600 ng/ml, which is more than twice the amount recommended by the FDA [5].
References
- Nørgaard B, Mogensen CB. Blood sample tube transportation system versus point of care technology in an ED; effect on time from collection to reporting? A randomized trial. SJTREM 2012; 20, 71. .
- Larsson A et al. The state of point of care testing: a european perspective. Ups J Med Sci 2015; 120,1: 1-10.
- St John A & Price C. Benefits of point of care testing in the emergency department. acutecaretesting.org 2018
- Von Eiff W et al. POCT-Management. Klinische und Ökonomische Effekte. Heidelberg: Medhochswei verlag 2013; 189-192.
- FDA Safety Communication on Biotin. Nov 2017 ~ Nov 2019